Problems and suggestions in the implementation of drug centralized volume-based procurement policies in the hospitals
10.3760/cma.j.cn111325-20231225-00437
- VernacularTitle:医疗机构落实药品集中带量采购政策中的问题及建议
- Author:
Weihua KONG
1
;
Qi QIAO
;
Guoqiang LIU
;
Nan CHEN
;
Chengwu SHEN
;
Qi CHEN
;
Feng QIU
;
Jianhua WANG
;
Ling JIANG
;
Qinghong LU
;
Junyan WU
;
Yafeng WANG
;
Likai LIN
;
Jiajia FENG
;
Hong CHENG
Author Information
1. 武汉大学医院管理研究所，武汉 430071
- Keywords:
Group purchasing;
National drug centralized volume-based procurement;
Medical insurance funds;
Retention of surplus funds;
Delphi method
- From:
Chinese Journal of Hospital Administration
2024;40(7):535-540
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the challenges in the implementation of drug centralized volume-based procurement policies in hospitals and propose corresponding optimization suggestions.Methods:From August to December 2023, a purposive sampling was conducted to select 11 pharmaceutical experts from tertiary hospitals in China for Delphi method. The survey content included " policy recommendations for promoting the acceleration and expansion of national drug centralized procurement and retaining surplus medical insurance funds for centralized procurement" .Results:Survey participants gave feedback on a set of existing problems found in the implementation of drug centralized procurement policies and proposed corresponding optimization methods. Kendall′s W coefficient of the specialist consultation was 0.332( P<0.05), demonstrating good consistency and concentration of the expert opinions. Among the problems, the score of drug supply guarantee was the highest(mean value of importance was 4.45). At the same time, the recommendation of strengthening monitoring and early warning, coordination and dispatch, and effectively ensuring the supply of centralized drug procurement had the highest score and concentration(mean value of importance was 4.91, coefficient of variation was 0.06). Conclusions:Through Delphi method, this study revealed issues and optimization methods in the implementation of drug centralized procurement policies in hospitals. The findings could provide valuable insights for improvements in the pharmaceutical sector and future policy adjustments.
